Covid-19 Pandemic
 Here’s the latest news from the global pandemic. Trump pitches second term with selective retelling U.K. steps up quarantine enforcement after criticism Hong Kong’s testing blitz is an experiment in trust Vaccine FOMO spurs smaller nations Some of the world’s wealthiest countries and regions—the U.S., the European Union and the U.K.—are locking up billions of the fastest-moving Covid-19 doses, while China and Russia are developing their own shots. So what are the lower- and middle-income countries doing? They’re developing vaccines in their own labs. There are about 50 inoculations under development in low-income countries, according to Airfinity Ltd., a London-based consultancy firm. Turkey and India lead with 10 projects apiece, but scientists in Thailand, Brazil, Argentina, Nigeria, Kazakhstan and other nations are advancing with experimental inoculations, Bloomberg’s James Paton reported this week.  A Covid-19 vaccine candidate ready for trial on monkeys in Thailand. Photographer: MLADEN ANTONOV/AFP There’s a “fear factor” that vaccine supplies won’t stretch beyond the top tier of wealthy countries, according to Seth Berkley, leader of Gavi, the Vaccine Alliance, which has been involved in efforts to secure doses for the rest of the world. But there’s more to it than that: Researchers in some developing countries say they want to make sure that immunizations are tailored to their populations, and that their local vaccine enterprise gains the strength to maintain protection against new infections that may arise in the future. Ultimately, the reality is that no one knows when vaccines will be ready or how effective they’ll be. No experimental shots have proved themselves in final-stage tests yet, and Airfinity estimates that it will take until the end of next year to distribute the first billion doses to the world. In the meantime, the number of coronavirus cases and deaths grow while schools and businesses around the world are stalled and looking for answers. There’s a fear of missing out on a vaccine that might end the pandemic.—John Lauerman Track the virus Mapping the Latest Covid-19 Outbreaks  Sponsored Content by Siemens America’s factories, power plants, transportation and hospitals all need technology and our technology is only as powerful as the people deploying and maintaining it. Keeping America moving takes more than technology alone. It takes a human touch. Siemens Ingenuity for life. What you should read U.S. Colleges Lose Favor With Asian Students Asian youth have never had more reason to reconsider U.S. education. Some Parents Take the School Year on the Road “Roadschooling” is emerging as an alternative for families in Covid era. Millions of Businesses Don’t Sell Online. It’s Time. Virus safety rules should persuade shops to experiment with e-commerce. U.K. Develops Mobile Broadcasts for Virus Alerts The “cell broadcast” system would use alerts targeted to certain locations. Thanks to Covid, Luxury Hotels Become Home Villas and vacation houses are out; year-long hotel stays are in. Know someone else who would like this newsletter? Have them sign up here. Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. Follow Us Get the newsletter You received this message because you are subscribed to Bloomberg’s Coronavirus Daily newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022 |
PreviousWork Zone Accidents